Literature DB >> 11557501

Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones.

L Alou1, M Ramirez, C García-Rey, J Prieto, H de Lencastre.   

Abstract

Analysis of the pulsed-field gel electrophoretic profiles of 82 pneumococcal isolates with reduced susceptibility to ciprofloxacin (RSC) and of 90 co-occurring susceptible isolates indicates a considerable genetic diversity among isolates with RCS and points to a close relation between the two groups. This finding suggests that pneumococci with RCS emerge through independent mutational events.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11557501      PMCID： PMC90763          DOI： 10.1128/AAC.45.10.2955-2957.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain.

Authors:  C García-Rey; L Aquilar; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae.

Authors:  T J Coffey; M C Enright; M Daniels; J K Morona; R Morona; W Hryniewicz; J C Paton; B G Spratt
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

4.  ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.

Authors:  R Muñoz; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

Authors:  S Soares; K G Kristinsson; J M Musser; A Tomasz
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

7.  Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.

Authors:  X S Pan; L M Fisher
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

8.  Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  M J Ferrándiz; A Fenoll; J Liñares; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

9.  Genetic diversity and clonal patterns among antibiotic-susceptible and -resistant Streptococcus pneumoniae colonizing children: day care centers as autonomous epidemiological units.

Authors:  R Sá-Leão; A Tomasz; I S Sanches; S Nunes; C R Alves; A B Avô; J Saldanha; K G Kristinsson; H de Lencastre
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 10.  Mechanisms and spread of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  E Varon; L Gutmann
Journal:  Res Microbiol       Date:  2000 Jul-Aug       Impact factor: 3.992
View more
  11 in total

1.  Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain.

Authors:  E Pérez-Trallero; C García-Rey; A M Martín-Sánchez; L Aguilar; J García-de-Lomas; J Ruiz
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

2.  High genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland.

Authors:  Ewa Sadowy; Radosław Izdebski; Anna Skoczyńska; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Increasing genetic relatedness of ciprofloxacin-resistant Streptococcus pneumoniae isolated in Canada from 1997 to 2005.

Authors:  Kimberly A Nichol; Heather J Adam; James A Karlowsky; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

4.  Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.

Authors:  Crystal N Johnson; William H Benjamin Jr; Stephen A Moser; Susan K Hollingshead; Xiaotian Zheng; Marilyn J Crain; Moon H Nahm; Ken B Waites
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.

Authors:  M D Pinho; J Melo-Cristino; M Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

6.  Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerases.

Authors:  María-Isabel Morosini; Elena Loza; Rosa del Campo; Felisa Almaraz; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

7.  Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada.

Authors:  Kimberly A Nichol; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis.

Authors:  Adela G de la Campa; María-José Ferrandiz; Fe Tubau; Román Pallarés; Federico Manresa; Josefina Liñares
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

9.  Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.

Authors:  Adela G de la Campa; Luz Balsalobre; Carmen Ardanuy; Asunción Fenoll; Emilio Pérez-Trallero; Josefina Liñares
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

10.  Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001.

Authors:  Pak-Leung Ho; Tak-Lun Que; Susan S Chiu; Raymond W H Yung; Tak-Keung Ng; Dominic N C Tsang; Wing-Hong Seto; Yu-Lung Lau
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.